MRI Sarcoma Non Invasive Thermometry
Completed · Phase 1/Phase 2
Conditions studied: Sarcoma
In brief
RATIONALE: Hyperthermia therapy kills tumor cells by heating them to several degrees above body temperature. Using MRI to measure heat may help to determine the effectiveness of hyperthermia therapy. Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy, such as ifosfamide and doxorubicin, work in different ways to stop tumor cells from dividing so they stop growing or die. Combining hyperthermia with radiation therapy and chemotherapy before surgery may kill more tumor cells and shrink the tumor so that it can be removed. PURPOSE: This phase I/II trial is studying the side effects of hyperthermia when given together with radiation therapy and optional chemotherapy and to see how well they work in treating patients who are undergoing surgery for soft tissue sarcoma of the limbs.
Key facts
- Study ID
- NCT00093509
- Run by
- Mark Dewhirst
- People needed
- 15
- Starts
- 1999-11-01
- Expected to finish
- 2009-10-01
- Last updated by the study team
- 2014-09-01
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients will have histologically proven grade 2 or grade 3 soft tissue sarcoma.
- Karnofsky performance status ≥ 70.
- Life expectancy ≥ 6 months.
- There is no specific tumor size limitation, but the involved extremity must fit within the hyperthermia applicator.
- Patients must be ≥ 18 years of age.
- Patients who are to receive chemotherapy must have a left ventricular ejection fraction on resting MUGA scan of at least 45% to confirm adequate cardiac function
- Patients must competent to consent to be in the study and sign an approved informed consent.
You may not qualify if…
- Pregnant patients
- Patients with cardiac pacemakers and implanted defibrillators or other devices not compatible with ultrasound or microwave technology
- Patients who have any metal in their bodies including orthopedic rods, surgical clips, bullets, or shrapnel, etc. unless cleared by MRI staff and Hyperthermia physicians
Where it is running
- Duke Cancer Institute — Durham, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.